Home › Ovarian Epithelial Carcinoma

Ovarian Epithelial Carcinoma clinical trials recruiting in the U.S.

25 studies for Ovarian Epithelial Carcinoma are recruiting participants at sites across the United States.

Cities with the most studies

• New York City, NY10 studies
• Boston, MA8 studies
• Durham, NC8 studies
• Cleveland, OH7 studies
• Houston, TX7 studies
• Baltimore, MD6 studies
• Chicago, IL6 studies
• Philadelphia, PA6 studies
• Salt Lake City, UT6 studies
• Edison, NJ5 studies
• Los Angeles, CA5 studies
• Minneapolis, MN5 studies
• Portland, OR5 studies
• San Diego, CA5 studies
• Queens, NY4 studies
• Seattle, WA4 studies
• New Haven, CT4 studies
• St. Louis, MO4 studies
• Shreveport, LA4 studies
• Indianapolis, IN4 studies
• Dallas, TX4 studies
• Arlington, VA4 studies
• Birmingham, AL4 studies
• Tampa, FL3 studies
• Billings, MT3 studies
• Oklahoma City, OK3 studies
• San Francisco, CA3 studies
• Columbus, OH3 studies
• Rochester, MN3 studies
• Norfolk, VA3 studies
• Dayton, OH3 studies
• West Palm Beach, FL3 studies
• Sioux Falls, SD3 studies
• Detroit, MI3 studies
• New Orleans, LA3 studies
• Washington, DC3 studies
• Pittsburgh, PA3 studies
• Providence, RI3 studies
• San Antonio, TX3 studies

By state

• Alabama4 studies
• Arizona3 studies
• California8 studies
• Connecticut4 studies
• Florida11 studies
• Illinois7 studies
• Indiana4 studies
• Louisiana6 studies
• Maryland8 studies
• Massachusetts9 studies
• Michigan5 studies
• Minnesota7 studies
• Missouri5 studies
• Montana3 studies
• New Jersey8 studies
• New York13 studies
• North Carolina9 studies
• Ohio11 studies
• Oklahoma3 studies
• Oregon6 studies
• Pennsylvania10 studies
• Rhode Island3 studies
• South Dakota3 studies
• Tennessee5 studies
• Texas12 studies
• Utah6 studies
• Virginia7 studies
• Washington6 studies
• Wisconsin3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.